Related Experiment Videos
Prion protein glycosylation
Victoria A Lawson1, Steven J Collins, Colin L Masters
1Department of Pathology, Centre for Neuroscience, and Mental Health Research Institute of Victoria, University of Melbourne, Parkville, Australia.
Journal of Neurochemistry
|April 29, 2005
Summary
Prion diseases, or transmissible spongiform encephalopathies, are neurodegenerative disorders. Glycosylation patterns of prion protein (PrP) show strain-specific properties, explaining disease variation in the protein-only prion model.
Area of Science:
- Neuroscience
- Molecular Biology
- Infectious Diseases
Background:
- Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases in humans and animals.
- The infectious agent, or prion, is primarily composed of an abnormal prion protein (PrP) isoform.
- The existence of distinct TSE strains challenges the protein-only replication model due to the absence of a nucleic acid genome.
Purpose of the Study:
- To review the role of glycosylation in prion protein (PrP) conversion to its disease-associated conformation.
- To explore glycosylation as a marker for identifying different transmissible spongiform encephalopathy (TSE) strain types.
Main Methods:
- Analysis of prion protein (PrP) conformation and glycosylation patterns.
- Examination of post-translational modifications in disease-associated PrP.
- Correlation of glycosylation with TSE strain characteristics.
Main Results:
- Post-translational modifications, specifically glycosylation, exhibit strain-specific properties.
- Glycosylation patterns contribute to the molecular basis of TSE strain variation.
- Glycosylation influences the susceptibility of cellular PrP to conversion.
Conclusions:
- Glycosylation plays a crucial role in understanding TSE strain diversity.
- Glycosylation patterns serve as a diagnostic marker for TSE strains.
- This highlights the importance of post-translational modifications in prion disease pathogenesis.